Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-14 6:20 pm Sale | 2026-03-31 | 13G | COGENT BIOSCIENCES INC COGT | Flynn James E | 9,043,903 5.290% | -9,215 (-0.10%) | Filing History |
| 2026-03-31 9:30 pm Sale | 2026-03-31 | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 15,356,918 8.600% | -905,000 (-5.57%) | Filing History |
| 2026-03-26 5:12 pm Sale | 2026-03-13 | 13G | COGENT BIOSCIENCES INC COGT | VANGUARD GROUP INC | 0 0.000% | -11,514,326 (Position Closed) | Filing History |
| 2026-02-17 4:42 pm Sale | 2025-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 2,802,905 1.800% | -7,405,155 (-72.54%) | Filing History |
| 2026-02-17 12:43 pm Sale | 2025-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Kynam Capital Management, LP | 6,165,223 4.330% | -1,720,949 (-21.82%) | Filing History |
| 2026-01-30 1:26 pm Purchase | 2025-12-31 | 13G | COGENT BIOSCIENCES INC COGT | VANGUARD GROUP INC | 11,514,326 7.500% | 6,979,671 (+153.92%) | Filing History |
| 2026-01-22 8:02 pm Purchase | 2026-01-22 | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 16,261,918 9.900% | 384,500 (+2.42%) | Filing History |
| 2026-01-21 3:47 pm Unchanged | 2025-12-31 | 13G | COGENT BIOSCIENCES INC COGT | BlackRock, Inc. BLK | 11,370,224 6.500% | 0 (Unchanged) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | COGENT BIOSCIENCES INC COGT | BlackRock, Inc. BLK | 11,370,224 6.500% | 4,614,640 (+68.31%) | Filing History |
| 2025-11-17 4:36 pm Purchase | 2025-11-13 | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 15,877,418 9.900% | 1,552,500 (+10.84%) | Filing History |
| 2025-11-14 4:57 pm Purchase | 2025-09-30 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 10,208,060 7.200% | 3,800,000 (+59.30%) | Filing History |
| 2025-11-14 4:34 pm Sale | 2025-09-30 | 13G | COGENT BIOSCIENCES INC COGT | Paradigm BioCapital Advisors LP | 3,156,398 2.300% | -7,196,051 (-69.51%) | Filing History |
| 2025-11-14 4:25 pm Purchase | 2025-09-30 | 13G | COGENT BIOSCIENCES INC COGT | TCG Crossover GP I, LLC | 6,798,162 4.800% | 1,167,120 (+20.73%) | Filing History |
| 2025-11-14 4:16 pm Sale | 2025-09-30 | 13G | COGENT BIOSCIENCES INC COGT | Point72 Asset Management, L.P. | 5,753,833 4.000% | -4,232,299 (-42.38%) | Filing History |
| 2025-11-14 12:36 pm Sale | 2025-09-30 | 13G | COGENT BIOSCIENCES INC COGT | Kynam Capital Management, LP | 7,886,172 5.540% | -1,353,559 (-14.65%) | Filing History |
| 2025-08-14 6:04 pm Sale | 2025-06-30 | 13G | COGENT BIOSCIENCES INC COGT | Venrock Healthcare Capital Partners II, L.P. | 4,755,411 4.200% | -1,691,506 (-26.24%) | Filing History |
| 2025-08-14 5:07 pm Purchase | 2025-07-07 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 6,408,060 5.500% | 1,138,836 (+21.61%) | Filing History |
| 2025-08-14 5:05 pm Sale | 2025-06-30 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 5,269,224 4.600% | -5,228,766 (-49.81%) | Filing History |
| 2025-08-14 4:31 pm Purchase | 2025-06-30 | 13G | COGENT BIOSCIENCES INC COGT | Paradigm BioCapital Advisors LP | 10,352,449 9.100% | 1,388,794 (+15.49%) | Filing History |
| 2025-07-14 4:31 pm Purchase | 2025-07-10 | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 14,324,918 9.900% | 2,994,777 (+26.43%) | Filing History |